Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.

Berke, Z; Andersen, M; Pedersen, M; Fugger, L; Zeuthen, J; Haurum, J

Journal article

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.

Abstract:: The Philadelphia (Ph) chromosome, resulting from the t(9;22) translocation, is characteristic of chronic myeloid leukemia (CML). As a result of this translocation, two novel chimeric genes are generated and the bcr/abl and abl/bcr fusion proteins expressed. The bcr/abl fusion mRNA is present in all CML patients, whereas the reciprocal abl/bcr fusion mRNA is detectable in about 80% of the Ph+ CML patients. These fusion proteins may undergo enzymatic degradation in the cytosol and give rise to MHC class I restricted peptide epitopes originating from the junctional regions of the translocation products, which thus may serve as novel tumor specific antigens. Previously, other groups have tested peptides corresponding to the junctional region of the bcr/abl protein for their binding capacity to HLA class I molecules and have identified a few candidate epitopes. Peptides originating from the abl/bcr fusion protein have on the other hand so far been neglected, for no apparent reason. We have now extended these studies to include also the reciprocal abl/bcr translocation product by testing a large panel of synthetic peptides corresponding to the junctional regions of both the abl/bcr and the bcr/abl fusion proteins for their ability to stabilize HLA class I molecules. We find that the abl/bcr translocation product may be an even more important source of CML specific peptide antigens and together the junctional sequences of both these proteins contain peptide sequences which bind efficiently to a number of HLA molecules (HLA-A1, -A2, -A3, -A11, -B7, -B27, -B35) and thus may serve as candidate CML specific tumor antigens.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Berke, Z., Andersen, M., Pedersen, M., Fugger, L., Zeuthen, J., & Haurum, J. (2000). Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules. Leukemia, 14(3), 419–426.

MLA Style

Berke, Z., et al. “Peptides Spanning the Junctional Region of Both the Abl/Bcr and the Bcr/Abl Fusion Proteins Bind Common HLA Class I Molecules.” Leukemia, vol. 14, no. 3, 2000, pp. 419–26.

Chicago Style

Berke, Z, M Andersen, M Pedersen, L Fugger, J Zeuthen, and J Haurum. 2000. “Peptides Spanning the Junctional Region of Both the Abl/Bcr and the Bcr/Abl Fusion Proteins Bind Common HLA Class I Molecules.” Leukemia 14 (3): 419–26.
Share
Print